We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Charles River Laboratories Enters Strategic Partnership With AstraZeneca
Charles River Laboratories Enters Strategic Partnership With AstraZeneca
October 17, 2012
Charles River Laboratories International announced it has been selected by AstraZeneca as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and pharmacokinetics). BusinessWire
